These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6324955)

  • 1. In vivo release of dopamine in the nucleus accumbens of the rat: modulation by cholecystokinin.
    Voigt MM; Wang RY
    Brain Res; 1984 Mar; 296(1):189-93. PubMed ID: 6324955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of cholecystokinin octapeptide-stimulated endogenous dopamine release from rat nucleus accumbens in vitro.
    Marshall FH; Barnes S; Pinnock RD; Hughes J
    Br J Pharmacol; 1990 Apr; 99(4):845-8. PubMed ID: 2361176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of cholecystokinin on the in vivo release of newly synthesized [3H]dopamine from the nucleus accumbens of the rat.
    Voigt MM; Wang RY; Westfall TC
    J Neurosci; 1985 Oct; 5(10):2744-9. PubMed ID: 4045551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo electrochemical analysis of cholecystokinin-induced inhibition of dopamine release in the nucleus accumbens.
    Lane RF; Blaha CD; Phillips AG
    Brain Res; 1986 Nov; 397(1):200-4. PubMed ID: 3801862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of cholecystokinin (CCK-8) on dopamine-containing nerve terminals in the caudate nucleus and nucleus accumbens of the anesthetized rat: an in vivo electrochemical study.
    Gerhardt GA; Friedemann M; Brodie MS; Vickroy TW; Gratton AP; Hoffer BJ; Rose GM
    Brain Res; 1989 Oct; 499(1):157-63. PubMed ID: 2804664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholecystokinin modulates the release of dopamine from the anterior and posterior nucleus accumbens by two different mechanisms.
    Marshall FH; Barnes S; Hughes J; Woodruff GN; Hunter JC
    J Neurochem; 1991 Mar; 56(3):917-22. PubMed ID: 1993898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotensin and cholecystokinin microinjected into the ventral tegmental area modulate microdialysate concentrations of dopamine and metabolites in the posterior nucleus accumbens.
    Laitinen K; Crawley JN; Mefford IN; De Witte P
    Brain Res; 1990 Jul; 523(2):342-6. PubMed ID: 1698106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Topographical analysis of nucleus accumbens sites at which cholecystokinin potentiates dopamine-induced hyperlocomotion in the rat.
    Crawley JN; Hommer DW; Skirboll LR
    Brain Res; 1985 Jun; 335(2):337-41. PubMed ID: 4005562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A possible mechanism of action of thyrotropin-releasing hormone (TRH) and its analog DN-1417 on the release of dopamine from the nucleus accumbens and striatum in rats.
    Narumi S; Nagai Y; Saji Y; Nagawa Y
    Jpn J Pharmacol; 1985 Dec; 39(4):425-35. PubMed ID: 2869169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal by cholecystokinin of apomorphine-induced inhibition of dopamine release in the nucleus accumbens of the rat.
    Blaha CD; Phillips AG; Lane RF
    Regul Pept; 1987 Jun; 17(6):301-10. PubMed ID: 3602473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased dopamine D2 receptor-mediated inhibition of [14C]acetylcholine release in the dorsomedial part of the nucleus accumbens.
    Russell VA; Allin R; Lamm MC; Taljaard JJ
    Neurochem Res; 1989 Sep; 14(9):877-81. PubMed ID: 2531849
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of cholecystokinin release from posterior nucleus accumbens by D-2 dopamine receptor.
    Martin JR; Beinfeld MC; Wang RY
    Brain Res; 1986 Nov; 397(2):253-8. PubMed ID: 2948613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the effects of serotonin on the release of [3H]dopamine from rat nucleus accumbens and striatal slices.
    Nurse B; Russell VA; Taljaard JJ
    Neurochem Res; 1988 May; 13(5):403-7. PubMed ID: 3165497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholecystokinin octapeptides alter the release of endogenous dopamine from the rat nucleus accumbens in vitro.
    Voigt M; Wang RY; Westfall TC
    J Pharmacol Exp Ther; 1986 Apr; 237(1):147-53. PubMed ID: 3958963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A thyrotropin releasing hormone analog, DN-1417, increases endogenous dopamine release from slices of rat striatum and nucleus accumbens.
    Yamada S; Kojima H; Tsutsumi T; Nakamura J; Anraku S; Nishi S; Inanaga K
    Kurume Med J; 1983; 30 Suppl():S29-35. PubMed ID: 6434800
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of chronic desipramine treatment on adrenoceptor modulation of [3H]dopamine release from rat nucleus accumbens slices.
    Nurse B; Russell VA; Taljaard JJ
    Brain Res; 1985 May; 334(2):235-42. PubMed ID: 3995319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo release of endogenous dopamine from rat caudate putamen and nucleus accumbens by 40 mM potassium chloride.
    Philips SR
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(4-6):817-20. PubMed ID: 6686714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of cholecystokinin octapeptide and dopamine on nucleus accumbens neurons.
    White FJ; Wang RY
    Brain Res; 1984 May; 300(1):161-6. PubMed ID: 6145498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apomorphine decreases stimulated dopamine release in rat nucleus accumbens but not in neostriatum: in vivo voltammetric data.
    Stamford JA; Kruk ZL; Millar J
    Eur J Pharmacol; 1987 Jul; 139(3):363-4. PubMed ID: 3666014
    [No Abstract]   [Full Text] [Related]  

  • 20. Nicotine infused into the nucleus accumbens increases synaptic dopamine as measured by in vivo microdialysis.
    Mifsud JC; Hernandez L; Hoebel BG
    Brain Res; 1989 Jan; 478(2):365-7. PubMed ID: 2924134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.